FibroGen (FGEN)

FibroGen Financial Statements

FibroGen Financial Overview

FibroGen's market cap is currently ―. The company's EPS TTM is $-3.04; its P/E ratio is -3.75; FibroGen is scheduled to report earnings on August 8, 2022, and the estimated EPS forecast is $-0.92. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 60.83M$ 16.54M$ 155.97M$ 24.36M$ 38.43M
Gross Profit$ 56.59M$ 13.42M$ 152.71M$ 21.29M$ 35.03M
EBIT$ -62.99M$ -135.24M$ 50.97M$ -133.84M$ -70.43M
EBITDA$ -60.41M$ -132.66M$ 53.56M$ -129.54M$ -65.09M
Net Income Common Stockholders$ -63.20M$ -134.08M$ 49.80M$ -133.99M$ -71.75M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 405.19M$ 428.07M$ 486.40M$ 507.21M$ 544.23M
Total Assets$ 745.93M$ 773.82M$ 850.51M$ 808.62M$ 787.30M
Total Debt$ 36.29M$ 37.09M$ 40.78M$ 96.93M$ 101.09M
Net Debt$ -368.90M$ -390.99M$ -445.62M$ -410.29M$ -443.14M
Total Liabilities$ 567.92M$ 544.71M$ 505.45M$ 528.77M$ 397.03M
Stockholders Equity$ 158.05M$ 209.15M$ 260.58M$ 325.79M$ 371.00M
Cash Flow
Free Cash Flow$ -45.11M$ -56.36M$ 17.68M$ -28.24M$ -45.50M
Operating Cash Flow$ -8.48M$ -54.96M$ 44.26M$ -26.54M$ -44.98M
Investing Cash Flow$ 25.93M$ -50.57M$ -122.15M$ -57.53M$ -196.72M
Financing Cash Flow$ -2.89M$ -31.00K$ -833.00K$ 2.38M$ -2.08M
Currency in USD

FibroGen Earnings and Revenue History

FibroGen Debt to Assets

FibroGen Cash Flow

FibroGen Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis